Purbanchal cancer hospital in Nepal has introduced PET/CT Positron emission tomography/computed tomography is a rapidly growing modality that has made a tremendous impact on the care of patients with cancer.
PET scans use a small amount of a radioactive substance, or tracer, to show differences between healthy tissue and diseased tissue.
The most commonly used tracer is 18F-FDG (Fluoro-deoxy-glucose).
The combination of PET/CT provides complete information about both structure (CT) and function (PET) in the human body.
Application of PET:
Oncological Application (>95%):
Lymphoma, Head and Neck Cancers, Lung cancer, Breast cancers, RCC, Gynaecological malignancies, Metastasis, Carcinoma of Unknown Primary etc.
Diagnosis of Malignancy
Staging of various cancers
Response Evaluation after Chemotherapy, Radiotherapy, Surgery or Immunotherapy